VacPertagen

Medicinal product

(Invented) name

VacPertagen

Active substance (s)

Bordetella pertussis antigenai: Kokliušo anatoksinas/Filamentinis hemagliutininas

Strength

5 µg/5 µg

Pharmaceutical form

injekcinė suspensija užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07AJ02, Pertussis, purified antigen

Marketing authorisation holder

BioNet Europe, Prancūzija

Date of authorisation

2026-01-09

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Vienoje dozėje (0,5 ml suspensijos) yra	0.5 ml
Bordetella pertussis antigenai: Kokliušo anatoksinas	5 µg
Filamentinis hemagliutininas	5 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119873	105979	1105979	užpildytas švirkštas	0,5 ml N1 (su adata)		Receptinis	EU/1/25/1999/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-01-09	Registruotas